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Summary One hundred and seventy-one cases of operable invasive lobular carcinoma, presenting over an
11-year period, were reviewed. Histological subtypes were investigated to determine differences in their clinical
behaviour and whether these differences could be explained by histopathological features. Five subtypes were
identified: mixed (45.6%), classical (30.4%), tubulo-lobular (13.5%), solid (6.4%) and alveolar (4.1%). The
median follow-up period was 64 months and the median age 54 years. The 12-year actuarial survival rate was
100% for the tubulo-lobular subtype, but only 47% for the solid variant. Similar differences were found in the
disease free interval, locoregional and distant metastatic rates between these two subtypes. The tubulo-lobular
tumours were more likely to be of good histological grade and node negative. The other three subtypes did not
differ significantly in their histopathological parameters, reflected in similar clinical behaviour. They occupied
an intermediate position between the other two subtypes in terms of prognosis.
Specific types of invasive adenocarcinoma of the breast may
be indentified by their distinctive differences in cell mor-
phology, growth patterns and tissue response (Gallagher,
1984). Approximately 65% of invasive tumours show no
characteristic features and are classified as 'no specific type'
or as 'ductal not otherwise specified' (Dixon et al., 1985). The
importance of the specific subtypes relates not only to
differences in their histological features but also to differences
in prognosis. Some have been shown to have a better and
others to have worse prognosis than breast carcinoma in
general (Dixon et al., 1985; Gallagher, 1984). Present know-
ledge of differences in clinical behaviour mainly concerns the
subtypes of invasive 'ductal' carcinomas (Gallagher, 1984).
Very little is known about the clinical behaviour of the
subtypes of invasive lobular carcinoma.
Lobular carcinoma is widely recognised as the commonest
specific type and is characterised by its cell type of uniform
small cells with rounded or oval nuclei and eccentrically
placed cytoplasm, often containing intracytoplasmic lumina
(Martinez, 1979). These cells resemble the cells seen in lob-
ular carcinoma in situ. Five subtypes or variants of invasive
lobular carcinomas have been well described previously (Fec-
hner, 1975; Fisher et al., 1979; Martinez, 1979; Dixon et al.,
1982). Each subtype is named according to its growth pat-
tern: (a) the classical variant (Fechner, 1975; Martinez, 1979),
which infiltrates in a diffuse manner through tissues without
architectural distortion and which has tumour cells that are
arranged in narrow cords, so called 'Indian files', and that
surround normal structures in a targetoid fashion; (b) the
solid variant (Fechner, 1975), which consists of sheets of
large groups of typical cells with little intervening stroma; (c)
the alveolar variant (Martinez, 1979), which consists of small
clusters of twenty or more cells and infiltrates in a similar
pattern as the classical variant; (d) the tubulo-lobular variant
(Fisher et al., 1979), where the tumour cells form microtu-
bular structures; and (e) a mixed subgroup (Dixon et al.,
1984) which, as the name indicates, consists of mixtures of
the other subtypes. Controversy still exists as to whether a
signet-ring cell type (Steinbrecher, 1976) belongs to either the
invasive 'ductal' or the invasive lobular groups. The inci-
dences of these subtypes varies in the literature, since
different pathologists used different cut-off levels in assigning
a histological section to a specific category (Dixon et al.,
1984).
We undertook this study to investigate our experience with
regard to invasive lobular carcinoma subtypes in order to
determine how they presented and whether more information
could be obtained about their clinical behaviour. We also
investigated whether histopathological features may explain
possible differences in clinical behaviour. Steroid receptor
status was investigated where available.
Patients and methods
Only patients with primary operable invasive breast car-
cinomas were included in this study. All these patients had
been treated in the Breast Unit at the City Hospital, Nottin-
gham under the care of one surgeon (R.W.B.).
Histology data
Histological sections of all invasive lobular cancers treated
over an 11-year period have been reviewed by two path-
ologists (I.O.E. and C.W.E.) to verify the specific diagnosis
of lobular carcinoma using the criteria outlined above (Mar-
tinez, 1979) and to allocate these tumours into five subgroups
(Fechner, 1975; Fisher et al., 1979; Martinez, 1979; Dixon et
al., 1982). In order to diagnose a specific subtype, at least
80% of a specific histological pattern was necessary to be
present in the sections. Using these criteria, five subtypes
have been identified, namely classical, solid, alveolar, tubulo-
lobular and mixed variants. The mixed variant was diagnosed
when a section contained more than one pattern but the
dominant pattern did not reach the 80% cut-off level. Signet
cell subtypes were not incorporated in the study.
All tumours were also graded by the same pathologists
(C.W.E. and I.O.E.) into well (grade 1), moderately (grade I1)
and poorly (grade III) differentiated categories using Elston's
modification of Bloom and Richardson's grading method
(Elston, 1987). Lymph nodes removed during operation were
routinely sectioned and evaluated for metastatic involvement.
Clinical data
Clinical data were obtained from reviewing the case notes of
all patients. The following data were completely available for
each case: tumour size and lymph node status, patient age,
recurrence patterns and distant metastatic involvement pat-
tern of organs, disease-free intervals and survival times. Dis-
tant metastatic involvement was recorded as determined clini-
cally during follow-up and verified by the relevant special
investigations.
Oestrogen and progesterone receptor status was deter-
mined in the majority of tumours, using the dextran-coated
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charcoal method (Nicholson et al., 1981). Levels of > 5 fmol
mg-' cytosol protein were taken to represent a positive result
for both receptors.
Primary treatment andfollow-up
All patients were treated by a simple mastsectomy, a sub-
cutaneous mastectomy or a lumpectomy followed by whole
breast irradiation. Lymph node status was determined by a
triple node biopsy technique (Haybittle, 1982). One node
was sampled from the lower axilla, the apex of the axilla and
the second intercostal space. No patient received adjuvant
systemic treatment.
All patients were followed up in a special post-surgical
treatment clinic after primary treatment. For the first 18
months they were seen at 3-monthly intervals. Between 18
and 60 months they were seen 6-monthly and thereafter on
an annual basis.
Locoregional recurrent disease was treated by local sur-
gery, local radiotherapy or both depending on the nature of
the recurrence. Distant metastatic disease was treated initially
with systemic hormonal manipulation.
Statistical methods
Life table analysis was used to compare the survival and
disease free intervals of the subtypes. The x2 method as
described by Mantel (1966) was applied to determine statis-
tical differences between two curves. To determine statistical
differences between more than two curves, the x2 method as
described by Armitage (1966) was used.
The ordinary X2 method, or Yates' correction for continuity
(Swinscour, 1987) where applicable, was used to determine
statistical differences between other parameters studied. A
specific subtype was compared with that of the remainder in
the series to determine whether significant differences exist
for each parameter investigated.
The Mann-Whitney U test (Goldstone, 1985) was used to
determine differences in follow-up periods and patient ages.
Results
During an 11-year period (October 1973 to October 1984),
1,254 patients with primary operable breast cancer (tumour
size < 5 cm diameter) were treated in the Breast Unit at the
City Hospital, Nottingham. One hundred and seventy-one of
these were classed as invasive lobular carcinomas. These
patients form the basis of this study. The median follow-up
time for the whole series was 64 months (3-156 months).
There were no significant differences in follow-up periods
comparing each subtype with the remainder. The median age
for the total series was 54 years (27-78 years). The median
age for each subgroup was: mixed group 55 years, classical
variant 53 years, tubulo-lobular variant 52 years, solid vari-
ant 57 years and alveolar variant 62 years. Differences were
not significant for these ages comparing each subtype with
the remainder.
Incidences
The incidences of the various subtypes identified were as
follows: mixed group 45.6% (n = 78), classical variant 30.4%
(n = 52), tubulo-lobular variant 13.5% (n = 23), solid variant
6.4% (n = 11) and alveolar variant 4.1% (n = 7).
Survival
The alveolar subtype was not incorporated in this analysis
because of the small number of cases in this group. In Figure
1 the survival curves of the four most common subtypes are
illustrated. Table I illustrates the summary of the statistical
analysis on survival of the four subtypes compared to each
other. The tubulo-lobular group had a much better survival
than the other subtypes. No patient in this group died of her
Table I Statistical comparison of survival rates
Subtype Classical Mixed Solid
Tubulo-lobular P<0.05 P<0.01 P<0.001
(tubulo-lobular) (tubulo-lobular) (tubulo-lobular)
Classical n.s. 0.10>P>0.05
(classical)
Mixed n.s. n.s.
X2 (subtype): subtype with better survival rate.
n.s. no significant difference.
disease after a maximum follow-up period of eleven years.
There does appear to be a rank order in survival between the
various subtypes. The 5-year actuarial survival rate for the
seven alveolar variant cases was 83% (data not illustrated).
Disease-free intervals
The alveolar subtype was again omitted from this analysis
because of the small number. In Figure 2 curves for disease-
free intervals (DFI) of the various subtypes can be seen.
Table II illustrates a summary of the statistical analysis on
DFI of the specific subtypes compared with each other.
Again the tubulo-lobular group was shown to be significantly
the best group and the solid group to be the worst group.
Comparing the results of the classical subtype with that of
the solid subtype also showed that the classical subtype did
significantly better. The 5-year actuarial disease-free rate for
the seven alveolar variant cases was 51% (data not illus-
trated).
Recurrence pattern
As illustrated in Table III, the tubulo-lobular subtype was
shown to recur significantly less frequently than the re-
mainder for both loco-regional (P<0.02) and distant recur-
rent disease (P<0.02). The solid subtype, however, was
shown to recur loco-regionally significantly more than the
remainder (P<0.02). No significant differences could be
found between the other subtypes compared with the
remainder for recurrent disease. There were no significant
differences between the various subtypes compared with the
remainder for distant metastatic involvement patterns (data
not illustrated).
Table II Statistical comparison of disease-free intervals
Subtype Classical Mixed Solid
Tubulo-lobular P<0.01 P<0.01 P<0.001
(tubulo-lobular) (tubulo-lobular) (tubulo-lobular)
Classical n.s. P<0.05
(classical)
Mixed n.s. 0.0> P>0.05
(mixed)
X2 (subtype): subtype with better disease-free interval.
n.s. no significant difference.
Table III Loco-regional recurrence and distant metastatic rates
Loco-regional Distant
Subtype Total no. recurrence metastasis
Mixed 78 32 (41%) 31 (40%
Classical 52 24 (46%) 23 (44%)
Tubulo-lobular 23 4 (17%) 3 (13%)
Solid 11 9 (82%) 6 (54%)
Alveolar 7 4 (57%) 4 (57%)
Mean of series 171 73 (43%) 67 (39%)
X': loco-regional recurrence, tubulo-lobular<remainder, P = <0.02;
solid> remainder, P = <0.02. Distant metastatic rate, tubulo-
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Tumour size and nodal status
By analysing nodal status without taking tumour size into
consideration, the tubulo-lobular group had a significantly
(P<0.05) lower node positive rate than the remainder (Table
IV).
When nodal status were analysed in relation to tumour
sizes <2 cm or >2 cm diameter the solid group showed a
significantly higher node positive rate for tumours <2 cm
diameter (P<0.01); the tubulo-lobular group still showed a
trend towards smaller tumours being less likely to be assoc-
iated with positive lymph nodes although the X2 value just
failed to reach significance (P = <0.1 but >0.05; Yates)
(Table IV).
For tumours >2 cm diameter no significant differences
could be found in comparing each subtype to the remainder
for node positive rates (Table IV).
Tumour differentiation
Grouping grades II and III and comparing them to grade I
tumours showed that the mixed group contained significantly
more tumours in the grades II and III categories than the
remainder (P<0.01; see Table V). The tubulo-lobular group
on the other hand contained significantly more tumours in
the well differentiated category (P<0.001; Table V).
Receptor status
No significant differences could be found comparing each
subtype with the remainder for oestrogen and progesterone
receptor status (see Table VI). However, dividing positive
oestrogen receptor status at the 100 fmol mg-' cytosol pro-
tein level showed that the solid and alveolar variants con-
tained significantly more cases with high oestrogen receptor
positive concentrations (P<0.05, both) (Table VI).
Bilateral cancers
Twenty-two cases out of 171 included in the study developed
metachronous contralateral cancers (13%) (Table VII). Ten
of these 22 cases presented in the mixed group (12.8%), nine
in the classical group (17.3%), two in the tubulo-lobular
group (8.7%) and one in the solid group (9.1%). No
significant differences could be demonstrated.
Table IV Nodal status versus tumour size
Tumour sizes
<2cm >2cm
Subtype Total Nodes (+) Total Nodes ( +)
Mixed 51 (65%) 19 (37%) 27 (35%) 15 (56%)
Classical 35 (67%) 13 (37%) 17 (33%) 10 (59%)
Tubulo-lobular 18 (78%) 3 (17%) 5 (22%) 2 (40%)
Solid 8 (73%) 7 (87%) 3 (27%) 1 (33%)
Alveolar 3 (43%) 1 (33%) 4 (57%) 2 (50%)
Mean of series 115 (67%) 43 (37%) 56 (33%) 30 (54%)
X2: tumour size <2 cm, nodes ( + ) rate: solid> remainder, P = <0.01;
tubulo-lobular <remainder, P = <0.1 but >0.05.
Table V Tumour differentiation
Tumour grade
Subtypes Total no. I II III
Mixed 78 7 ( 9%) 55 (70%) 16 (21%)
Classical 52 7 (13%) 39 (75%) 6 (12%)
Tubulo-lobular 23 17 (74%) 6 (26%) 0
Solid 11 2 (18%) 6 (55%) 3 (27%)
Alveolar 7 1 (14%) 4 (57%) 2 (29%)
Mean of series 171 34 (20%) 110 (64%) 27 (16%)
X2: grades II and III, mixed>remainder, P= <0.01; tubulo-
lobular<remainder, P = <0.001.
Table VI Receptor status
Oestrogen receptor Progesterone receptor
(ER) (PR)
(+ )>100
Subtype Total no. Total ( + ) fmolmg' Total no. Total ( +)
Mixed 64 45 (58%) 11 (17%) 42 13 (31%)
Classical 38 21 (55%) 4 (11%) 21 10 (48%)
Tubulo-lobular 15 11 (73%) 3 (20%) 11 7 (64%)
Solid 10 7 (70%) 5 (50%) 5 1 (20%)
Alveolar 6 5 (83%) 4 (67%) 5 3 (61%)
Mean of series 133 89 (67%) 27 (20%) 84 34 (41%)
X2: ER ( + )> 100 fmol mg-', solid> remainder, P = <0.05; alveolar-
>remainder, P = <0.05.
Table VII Bilateral invasive carcinoma rates
No. bilateral No. bilateral carcinomas
Subtype Total no. carcinomas per 1,000 patient years
Mixed 78 10 (13%) 25.6
Classical 52 9 (17%) 34.6
Tubulo-lobular 23 2 ( 9%) 17.4
Solid 11 1 ( 9%) 18.2
Alveolar 7 0 (-)
Mean of series 171 22 (13%) 23.8
I2:no significant differences between subtypes.
Of 342 patients with invasive 'ductal' cancers treated in
this unit during the same period of time and matched with
the 171 cases included in this study on a one to two basis for
stage and age, 10 (3%) have developed contralateral malig-
nancies. This amounts to an incidence of 5.8 cancers per
1,000 woman years for ductal carcinomas (data not illus-
trated).
Discussion
There is little published work on the behaviour and charac-
teristics of the subtypes of invasive lobular carcinomas
(Dixon et al., 1982). This is probably due to their recent
recognition and their low frequency, although some other
special types of breast cancer are also relatively rare. Their
clinical relevance was also not known until recently and
therefore there was previously little need to subtype invasive
lobular carcinomas.
Approximately 60 possible results were obtained in this
study by analysing all the various parameters for differences
between each subtype and the remainder. There were also
large differences in the total number of cases studied in the
subtypes. It is therefore important to acknowledge that pure-
ly by chance alone, significant differences could arise in three
results with P values of <0.05 and one result with a P value
of <0.01. However, taking this into account, certain trends
still remain.
Identifying subtypes of invasive lobular carcinomas by
strict histological criteria seems to provide useful clinical
information. This study, like that of Dixon et al. (1982),
illustrates the varying prognosis of these various subtypes
(Figure 1). The differences in survival appear to be a
reflection of the primary tumour's local aggressiveness and
ability to metastasise. It was noted that the locoregional
recurrence rate of each subtype closely correlates with its
distant metastatic rate (Table III). This tendency is shown to
relate to factors predicting prognosis such as node positivity
(Table IV) and tumour differentiation (Table V). These fac-
tors also differ between the variants in approximately the
same manner as they differ in their survival and disease-free
intervals.
The tubulo-lobular subtype has been shown to carry the
best prognosis of all the variants investigated (Figure 1).
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likely to have involved regional lymph nodes compared with
the other subtypes (Table IV). This group also contained
more well differentiated tumours than the remainder of the
subtypes (Table V). However, grading is biased in that tubule
formation, a component of grade (Elston, 1987), is only seen
in this subtype. All these favourable prognostic features are
reflected not only in a better survival rate but also in a better
disease-free interval compared with the other subtypes
(Figures 1 and 2). Tubulo-lobular carcinomas recurred less
commonly than the remainder, not only loco-regionally but
also distantly (Table III); they had the best prognosis of all
the invasive lobular carcinoma subtypes investigated and pos-
sibly of breast carcinoma in general. This subtype was not
included in the study of Dixon et al. (1982).
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The solid subtype on the other hand, has been shown to
carry the worst prognosis (Figure 1), which confirms the
finding of Dixon et al. (1982). It metastasised more fre-
quently to regional lymph nodes than the other subtypes
even if the tumour was of small size (Table IV). This subtype
also tended to recur more often loco-regionally than the
other subtypes (Table III), as can be expected from a tumour
having poor prognostic features such as a high node positive
rate (Table IV) and poor differentiation (Table V). This
might be an important fact to consider if breast conserving
therapy is offered as primary treatment for patients with
these lesions. Two of the 11 patients with the solid tumour
subtype in this series had been treated with breast conserving
operations and both developed local recurrences.
There were no significant differences between the other
three variants in general. The classical subtype fared second
best in terms of survival (Figure 1) and disease-free intervals
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Figure 2 Disease-free interval. Symbols as in Figure 1.
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(Figure 2). This subtype and the mixed subtype formed the
two largest groups in the series. They occupied an inter-
mediate position between the other two subtypes already
discussed in terms of prognosis (Figure 1), which in turn
correlates with the expression of their histopathological prog-
nostic features investigated (Tables IV and V).
The alveolar variant was the smallest group in the study,
which made it difficult to demonstrate any differences bet-
ween it and the other subtypes. This subtype was shown by
Dixon et al. (1982) to have a fairly good prognosis although
they too only studied 19 cases out of a total of 103 cases. We
have shown that the alveolar subtype contained more tum-
ours with a very high positive oestrogen receptor level com-
pared to the other subtypes (Table VI). This had previously
been illustrated by other workers (Shousha et al., 1986).
Bilateral cancer is more common in patients with lobular
than ductal carcinoma (Wheeler, 1976). In this series the total
of 22 cases amounts to an incidence of 23.8 cancers per 1,000
women years (Table VII). This compares with 5.8 per 1,000
women years in our matched group with invasive ductal
cancer, and is clearly different. There were no differences in
contralateral malignancy when subtypes were compared
(Table VII).
In conclusion two studies now show subtyping of invasive
lobular carcinomas to have prognostic and possibly manage-
ment implications. Patients with the tubulo-lobular subtype
appear to have a very favourable prognosis. Patients presen-
ting with the solid variant should be followed carefully after
primary treatment for the development of local recurrences,
especially if treated by breast conservation. The small num-
ber of cases in some variants makes it difficult to investigate
them properly for prognosis. More studies are required to
ratify our findings.
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